Alvin Zipursky Selected Research

Down Syndrome (Down's Syndrome)

6/2006	Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome.
1/2005	Origins of leukaemia in children with Down syndrome.
6/2003	GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.
1/2002	Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alvin Zipursky Research Topics

Disease

4	Down Syndrome (Down's Syndrome) 06/2006 - 01/2002
3	Kernicterus 01/2018 - 06/2011
2	Perinatal Death 01/2018 - 02/2015
2	Stillbirth 01/2018 - 02/2015
2	Leukemia 06/2006 - 01/2002
1	Hyperbilirubinemia 02/2015
1	Neurologic Manifestations (Neurological Manifestations) 02/2015
1	Neonatal Jaundice 06/2011
1	Jaundice (Icterus) 06/2011
1	Neoplasms (Cancer) 01/2002

Drug/Important Bio-Agent (IBA)

3	BilirubinIBA 01/2018 - 06/2011
2	Biological ProductsIBA 06/2006 - 01/2005
1	Oxidoreductases (Dehydrogenase)IBA 06/2011
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2006
1	GATA1 Transcription FactorIBA 06/2003
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2002

Therapy/Procedure

1	Phototherapy (Light Therapy) 06/2011
1	Drug Therapy (Chemotherapy) 06/2006